Bendamustine/Obinutuzumab Followed by Obinutuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bendamustine and obinutuzumab followed by obinutuzumab that may be used in the treatment of some forms of non-Hodgkin's lymphoma (NHL), including follicular lymphoma, gastric and nongastric, noncutaneous mucosa-associated lymphoid tissue (MALT) lymphoma, and nodal and splenic marginal zone lymphoma.

**Synonyms:** - Bendamustine Plus Obinutuzumab Followed by Obinutuzumab Regimen - Bendamustine-Obinutuzumab Followed by Obinutuzumab - Bendamustine-Obinutuzumab Followed by Obinutuzumab Regimen - Bendamustine/Gazyva Followed by Gazyva Regimen - Bendamustine/Obinutuzumab Followed by Obinutuzumab - Obinutuzumab/Bendamustine Followed by Obinutuzumab